Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense

Overview of attention for article published in BMC Cancer, January 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 55 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

METHOD OF TARGETING ONCOLYTIC VIRUSES TO TUMORS

Application EP-4268838-A3

European Patent Office

METHOD OF TARGETING ONCOLYTIC VIRUSES TO TUMORS

Application EP-4268838-A2

European Patent Office

METHOD OF TARGETING ONCOLYTIC VIRUSES TO TUMORS

Application EP-3515462-A4

European Patent Office

METHOD OF TARGETING ONCOLYTIC VIRUSES TO TUMORS

Application WO-2018053529-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.